Strain Profile · NCBI Strain Taxon 486408
Save

Lacticaseibacillus rhamnosus HN001

◐ Food-origin
Sequenced
Public genome assembly available

Lacticaseibacillus rhamnosus HN001 (formerly classified as Lactobacillus rhamnosus HN001) has been studied across in vitro, animal, and human randomized controlled trial settings. In vitro research has examined activity against certain bacterial and fungal pathogens under laboratory conditions, while RCT-level evidence has examined constipation, IBS symptoms, and pregnancy-related outcomes. Animal model work has examined immune modulation and gut barrier function, though findings in animal models do not always translate directly to human outcomes. The available evidence is early to moderate in maturity; individual results may vary and this strain should not be viewed as a treatment for any specific condition. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 157 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+6 more systems

Symptoms in the research

Share of this strain's 84 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+15 more symptoms

Research

213 papers reference this strain in the probiotic database.

Match confidence
2026 IN_VITRO
Dataset for Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
· AgResearch
2026 RCT
Probiotic effects on brain health are both transient and sustained for several weeks after discontinuation: a randomised controlled trial
· Communications Medicine
2026 IN_VITRO
Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
· AgResearch
2026 IN_VITRO
Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
· Frontiers in Physiology
2026 RCT
Two-strain probiotic supplementation ameliorates physiological responses to running in the heat
· Physiology
2026 RCT
Effects of a strain-specific probiotic formulation on subjective sleep quality: a randomized, double-blind study
· Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
2025 OTHER
Probiotic strain identification and safety assessment of unlabeled bacteria in infant products
· International Journal of Food Microbiology
2025 RCT
Micro-encapsulation differentially impacts probiotic effects on brain structure and function in an elderly population – A randomised placebo-controlled trial
· Brain Behavior and Immunity
2025 ANIMAL
Reproductive experience influences the effects of Lactocaseibacillus rhamnosus HN001 on gut microbiota and hippocampal plasticity in female rats
· Journal of Neuroendocrinology
2025 IN_VITRO
Tradescantia spathacea extract as biostimulating in growth and biological activities of Lactobacillus acidophilus and Lacticaseibacillus rhamnosus
· Ecosistemas y Recursos Agropecuarios
2025 REVIEW
The therapeutic effects of Lacticaseibacillus rhamnosus on stress-induced anxiety: a systematic review of evidence from animal studies
· Gut Microbiome
2024 IN_VITRO
Sodium Deoxycholate-Propidium Monoazide Droplet Digital PCR for Rapid and Quantitative Detection of Viable Lacticaseibacillus rhamnosus HN001 in Compound Probiotic Products
· Microorganisms
2024 IN_VITRO
Antagonistic and antibacterial activity of Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 included in the oral probiotic
· Journal of obstetrics and women s diseases
2023 IN_VITRO
Inhibition of Toxic Shock Syndrome-Associated Staphylococcus aureus by Probiotic Lactobacilli
· Microbiology Spectrum
2023 RCT
A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial
· Microorganisms
2022 RCT
Adjuvant use of multispecies probiotic in the treatment of peri‐implant mucositis: A randomized controlled trial
· Journal Of Clinical Periodontology
2022 ANIMAL
Lactobacillus rhamnosus HN001 Ameliorates BEZ235-Induced Intestinal Dysbiosis and Prolongs Cardiac Transplant Survival
· Microbiology Spectrum
2022 REVIEW
Renaissance of the vaginal microbiota: reframing clinical paradigms
· Russian Journal of Woman and Child Health
2021 ANIMAL
The Possible Role of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 on Locomotor Activity and Oxidative Stress in a Rotenone‐Induced Zebrafish Model of Parkinson’s Disease
· Oxidative Medicine and Cellular Longevity
2021 RCT
Effect of Lactobacillus rhamnosus Probiotic in Early Pregnancy on Plasma Conjugated Bile Acids in a Randomised Controlled Trial
· Nutrients
Browse all 213 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
    · AgResearch · 2026
    Source →
  2. [2]
    Probiotic effects on brain health are both transient and sustained for several weeks after discontinuation: a randomised controlled trial
    · Communications Medicine · 2026
    PMID 42521749 →
  3. [3]
    Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
    · Frontiers in Physiology · 2026
    PMID 42180834 →
  4. [4]
    Dataset for Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
    · AgResearch · 2026
    Source →
  5. [5]
    Adjuvant use of multispecies probiotic in the treatment of peri‐implant mucositis: A randomized controlled trial
    · Journal Of Clinical Periodontology · 2022
    PMID 35634695 →
  6. [6]
    Effects of Lactobacillus rhamnosus HN001 in Early Life on the Cumulative Prevalence of Allergic Disease to 11 Years
    · PEDIATRICS · 2019
    Source →
  7. [7]
    Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years
    · Pediatric Allergy and Immunology · 2018
    PMID 30430649 →
  8. [8]
    Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study
    · BMC Infectious Diseases · 2018
    PMID 29540160 →
  9. [9]
    Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial
    · EBioMedicine · 2017
    PMID 28943228 →
  10. [10]
    Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial
    · British Journal Of Nutrition · 2017
    PMID 28367765 →